GENESIS Pharma is a biopharmaceutical company specializing in the commercialization of innovative pharmaceutical products for serious and rare diseases in Central and Eastern Europe. Established in 1997, GENESIS Pharma was the first pharmaceutical company in Greece and one of the first in Europe to focus on the sales, marketing and distribution of biopharmaceutical products. Shortly after its founding, the company began to steadily expand at a regional level, today covering most countries in the CEE region through the affiliated company GENESIS Pharma (Cyprus) Ltd.
The robust network of its strategic partnerships comprises leading international pharmaceutical companies dedicated to cutting-edge R&D, alongside fast-growing biopharmaceutical companies with pioneering research and disruptive innovations in the development of targeted, specialized treatments for orphan diseases.
In total, GENESIS Pharma holds a product portfolio covering over 30 serious and rare diseases, predominantly within the therapeutic areas of neurology, genetic diseases, oncology, hematology, rheumatology, dermatology, nephrology, gastroenterology, and cardiology.
In Greece, the company is the largest among Greek companies specializing in innovative medicines, based on turnover, as well as one of the most awarded companies for its commitment to sustainable development and good working environment.
Genesis Pharma S.A. – Headquarters, Greece
270 Kifissias Avenue, Halandri
GR-15232, Athens, Greece
Tel.: +30 210 877 1500
Email: info@genesispharma.com
Genesis Pharma (Cyprus) Ltd – Cyprus
Consulco Building
73 Metochiou Street, 2nd & 3rd Floor
2407 Engomi, Nicosia, Cyprus
1684 Nicosia, P.O. BOX 23638
Tel.: +357 22 765715
Email: info-cyprus@genesispharmagroup.com
- Awards
Since 2000, GENESIS Pharma has received numerous awards and certifications in recognition of its growth, innovation, productivity, commitment to excellence, working environment, and corporate responsibility performance.
Among its most notable distinctions for business performance are its ranking among the fastest-growing companies in Europe in the EUROPE’S 500 list (2006), the European recognitions EFQM Committed to Excellence and EFQM Recognized for Excellence – 4 Star (2009, 2013), and its inclusion among the 110 top businesses in Europe in the European Business Awards (Ruban d’ Honneur 2014/15).
For its consistent commitment to sustainability, GENESIS Pharma is one of the most awarded companies in the Greek Corporate Responsibility Index (CR Index), with continuous distinctions since 2009, currently holding the highest DIAMOND ranking. Since 2021, the company has also been included in the annual list of The Most Sustainable Companies in Greece by the QualityNet Foundation. Both evaluations are aligned with the international ESG criteria.
Moreover, GENESIS Pharma is the most awarded organization for its working environment in the Best Workplaces competition, with 19 national and European awards in total from 2003 to date.
- Certifications
